Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases-Reference-Cited by-同舟云学术

Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases

Published:2007 Issue:5 Volume:72B Page:363-370
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Klabusay Martin,Sukova Vera,Coupek Petr,Brychtova Yvona,Mayer Jiri

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference38 articles.

1. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

2. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

3. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

4. Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma;Cell Death Discovery;2022-12-31

2. Two types of high inductive electromagnetic stimulation and their different effects on endothelial cells;Physiological Research;2019-08

3. Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual-combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR];Journal of Pharmaceutical Investigation;2018-08-27

4. Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen;Current Pharmaceutical Design;2018-06-27

5. Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia;Leukemia & Lymphoma;2017-02-07